Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma

Detalles Bibliográficos
Autores principales: Sgherza, Nicola, Curci, Paola, Strafella, Vanda, Rizzi, Rita, Musto, Pellegrino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182598/
https://www.ncbi.nlm.nih.gov/pubmed/33988136
http://dx.doi.org/10.23750/abm.v92i2.11395
_version_ 1783704241756438528
author Sgherza, Nicola
Curci, Paola
Strafella, Vanda
Rizzi, Rita
Musto, Pellegrino
author_facet Sgherza, Nicola
Curci, Paola
Strafella, Vanda
Rizzi, Rita
Musto, Pellegrino
author_sort Sgherza, Nicola
collection PubMed
description
format Online
Article
Text
id pubmed-8182598
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-81825982021-06-16 Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma Sgherza, Nicola Curci, Paola Strafella, Vanda Rizzi, Rita Musto, Pellegrino Acta Biomed Correspondence Mattioli 1885 2021 2021-05-12 /pmc/articles/PMC8182598/ /pubmed/33988136 http://dx.doi.org/10.23750/abm.v92i2.11395 Text en Copyright: © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Correspondence
Sgherza, Nicola
Curci, Paola
Strafella, Vanda
Rizzi, Rita
Musto, Pellegrino
Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma
title Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma
title_full Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma
title_fullStr Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma
title_full_unstemmed Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma
title_short Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma
title_sort implications of interleukin-6 (il-6)-blockade for severe covid-19 infection in patients with multiple myeloma
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182598/
https://www.ncbi.nlm.nih.gov/pubmed/33988136
http://dx.doi.org/10.23750/abm.v92i2.11395
work_keys_str_mv AT sgherzanicola implicationsofinterleukin6il6blockadeforseverecovid19infectioninpatientswithmultiplemyeloma
AT curcipaola implicationsofinterleukin6il6blockadeforseverecovid19infectioninpatientswithmultiplemyeloma
AT strafellavanda implicationsofinterleukin6il6blockadeforseverecovid19infectioninpatientswithmultiplemyeloma
AT rizzirita implicationsofinterleukin6il6blockadeforseverecovid19infectioninpatientswithmultiplemyeloma
AT mustopellegrino implicationsofinterleukin6il6blockadeforseverecovid19infectioninpatientswithmultiplemyeloma

Ejemplares similares